These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 173487)

  • 21. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].
    Cret L; David M; Macabéo V; Frédérich A; Jeune M
    Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tetracosactide (Synacthen Depot) in patients with multiple sclerosis].
    Kanić M; Sepcić J
    Lijec Vjesn; 1992; 114(5-8):134-6. PubMed ID: 1343045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma cortisol responses to cortrosyn treatment in asthmatic children.
    Bolodeoku JO; Onadeko BO; Aderele WI
    Afr J Med Med Sci; 1982 Mar; 11(1):19-22. PubMed ID: 6291354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New aspects of ACTH therapy (proceedings)].
    Kaiser H
    Z Rheumatol; 1976; 35 Suppl 4():suppl 477-82. PubMed ID: 185842
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse reactions to nitrofurantoin in relation to cellular and humoral immune responses.
    Bäck O; Lidén S; Ahlstedt S
    Clin Exp Immunol; 1977 Jun; 28(3):400-6. PubMed ID: 891020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Discussion of a case of dyschromia].
    Nicolay M; Piot V
    Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lymphocyte blast transformation according to the clinical variant of rheumatoid arthritis].
    Popova L; Pekhlivanov D; Matev M; Apostolov P; Sheĭtanov I
    Vutr Boles; 1980; 19(2):39-43. PubMed ID: 6966867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [7-Methyltryptophan9]-beta-corticotropin-(1-24): a hyperactive Synacthen analogue.
    Allen MC; Bailey PD; Brundish DE; Jones JH; Wade R; Young GT
    Int J Pept Protein Res; 1984 Nov; 24(5):529-31. PubMed ID: 6097558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synacthen therapy and prostatic carcinoma?].
    Staehler W; Ziegler H
    Med Welt; 1975 Apr; 26(14):682. PubMed ID: 169454
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tetracosactid (Synacthen) as a therapeutic alternative in uveitis and other chronic inflammations of the eye].
    Fricke HJ; Heydenreich A; Thiel U; Schröder D
    Klin Monbl Augenheilkd; 1983 Jul; 183(1):10-6. PubMed ID: 6310203
    [No Abstract]   [Full Text] [Related]  

  • 31. [Synacthene-Retard in mental confusion of aged patients].
    Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G
    Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577
    [No Abstract]   [Full Text] [Related]  

  • 32. A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome.
    Ohya T; Nagai T; Araki Y; Yanagawa T; Tanabe T; Iyoda K; Kurihara M; Yamamoto K; Masunaga K; Iizuka C; Nagamitsu S; Yamashita Y; Awaya Y; Maekawa K; Matsuishi T;
    Brain Dev; 2009 Nov; 31(10):739-43. PubMed ID: 19118960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
    Emery P; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Jul; 57(1):123-9. PubMed ID: 6611230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience using sinakten-retard in the treatment of muscular sclerosis].
    Neretin VIa; Kir'iakov VA; Pegova LN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):514-8. PubMed ID: 207061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
    Bordier C; Flechet ML; Thomine E; Lauret P
    Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
    [No Abstract]   [Full Text] [Related]  

  • 37. Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup.
    Taylor WJ; Rajapakse CN; Harris KA; Harrison AA; Corkill MM
    J Rheumatol; 1999 Dec; 26(12):2544-50. PubMed ID: 10606361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Allergic reactions to tetracosactrin.
    Mohr PD
    Br Med J; 1975 Oct; 4(5989):162. PubMed ID: 172182
    [No Abstract]   [Full Text] [Related]  

  • 39. Short course of synacthen therapy as an adjunct in the management of rheumatoid arthritis.
    Ben-Chetrit E; Naparstek Y; Ehrenfeld M; Eliakim M
    Clin Rheumatol; 1985 Jun; 4(2):155-60. PubMed ID: 2988847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell mediated immunity in rheumatoid arthritis: Imparied lymphocyte responsiveness, humoral immunosuppressants, and correlations with clinical status in patients off drug therapy.
    Lloyd TM; Panush RS
    J Rheumatol; 1977; 4(3):231-44. PubMed ID: 926101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.